Concurrent Elevation of CEA and CA 19-9 in a Patient with Allergic Bronchopulmonary Aspergillosis: A Case Report and Literature Review.
Аннотация
OBJECTIVE
Serum carbohydrate antigen (CA 19-9) and carcinoembryonic antigen (CEA) are common tumor markers that are mainly used in the diagnosis and therapeutic evaluation of malignant tumors. Here, we detail a case of allergic bronchopulmonary aspergillosis (ABPA) presenting with elevation of CEA and CA 19-9 levels.
CASE REPORT: A 22-year-old non-asthmatic male presented with recurrent cough, white mucopurulent sputum, and elevated serum CEA (20.55 ng/mL) and CA 19-9 (>1000 U/mL) levels. Investigations revealed Aspergillus-positive sputum culture, central bronchiectasis, mucus plugs on CT, eosinophilia, and migratory pulmonary lesions. Initial voriconazole therapy failed to prevent relapses. ABPA diagnosis was confirmed after re-evaluation. Combined voriconazole and methylprednisolone treatment achieved sustained remission over three years with normalization of tumor markers.
RESULTS
Elevation of CEA and CA 19-9 levels correlated with ABPA disease activity but not IgE/eosinophil levels. Post-treatment normalization of CEA and CA 19-9 levels supports their utility as inflammatory biomarkers. This case expands the ABPA phenotype and cautions against misinterpreting tumor markers as malignancy indicators in benign inflammatory contexts.
CONCLUSION
ABPA should be considered in non-asthmatic patients with recurrent respiratory symptoms and elevated tumor markers. Serial monitoring of CEA/CA 19-9 may aid therapeutic assessment.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.